Endoscopic follow-up of 383 patients with colorectal adenoma: an observational study in daily practice

被引:16
|
作者
Jonkers, Daisy [1 ]
Ernst, Justi [1 ]
Pladdet, Ingrid [1 ]
Stockbrugger, Reinhold [1 ]
Hameeteman, Wirn [1 ]
机构
[1] Univ Hosp Maastricht, Dept Gastroenterol & Hepatol, NL-6202 AZ Maastricht, Netherlands
关键词
colorectal cancer; adenoma; follow-up surveillance; compliance;
D O I
10.1097/01.cej.0000195710.56825.b1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endoscopic removal of colorectal adenomas reduces the incidence and mortality of colorectal cancer (CRC), but follow-up surveillance is recommended. Compliance with the Dutch surveillance guidelines and detection of neoplasia during follow-up has been evaluated in daily practice. From 1987 to 1996, 383 consecutive patients with colorectal adenomas (56.4% male, 61.8 +/- 11.3 years) were included and followed until December 2000. The mean follow-up was 80.5 +/- 42.5 months with 2.2 +/- 0.9 follow-up endoscopies. A total of 32.5 and 27.3% of follow-up endoscopies were performed > 25% (time between advised and actual endoscopy) too late or too early, respectively. At the end of follow-up, 33.4% of patients had left the follow-up (two-thirds died) and 60.1% were known with co-morbidity. A first, second, third, fourth and fifth follow-up endoscopy had been performed in 327, 238,132, 64 and 35 patients, respectively. Adenomatous polyps (with high-risk polyps) were detected in 100% (42.6%) of the index endoscopies and in 25.1% (17.4%), 23.9% (10.5%), 28.0% (12.1%), 34.4% (25.0%) and 37.1 % (17.1 %) of the first to fifth follow-up endoscopy, respectively. CRC was diagnosed in seven patients (46.1 +/- 22.9 months after index endoscopy), resulting in a standardized incidence ratio of 1.4 (confidence interval 0.6-3.0, P=0.4) compared to the general population. In this daily practice, high numbers of total and high-risk adenomatous polyps were found during follow-up surveillance. The incidence of CRC was not significantly different from the general population, which might be due to the intensive follow-up and removal of polyps. These findings support the importance of follow-up surveillance. However, the high overall morbidity and mortality should be taken into account when selecting patients for an intensive follow-up programme. European Journal of Cancer Prevention 15:202-210 (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [41] ENDOSCOPIC CHARACTERISTICS, TREATMENT AND FOLLOW-UP OF COLORECTAL LATERALLY SPREADING TUMOURS
    Kan, Zilin
    Jin, Peng
    GUT, 2018, 67 : A62 - A62
  • [42] EARLY COLORECTAL-CANCER - FOLLOW-UP AFTER ENDOSCOPIC POLYPECTOMY
    SPERONI, AH
    MEISS, RP
    CALZONA, C
    CASTELLETTO, RH
    JMELNITZKY, A
    CHOPITA, N
    VACCAREZZA, CM
    RUBIO, HH
    ENDOSCOPY, 1988, 20 (01) : 18 - 20
  • [43] Follow-Up Examination of the Recurrence After Endoscopic Treatment of Colorectal Tumors
    Komeda, Yoriaki
    Kashida, Hiroshi
    Sakurai, Toshiharu
    Asakuma, Yutaka
    Nagai, Tomoyuki
    Matsui, Shigenaga
    Watanabe, Tomohiro
    Kudo, Masatoshi
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB392 - AB392
  • [44] Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer
    Cooper, GS
    Yuan, Z
    Chak, A
    Rimm, AA
    GASTROINTESTINAL ENDOSCOPY, 2000, 52 (01) : 33 - 38
  • [45] FOLLOW-UP OF PATIENTS DIAGNOSED AS LEIOMYOMAS ON ENDOSCOPIC ULTRASONOGRAPHY
    SHAH, S
    GERDES, H
    BOTET, J
    LEVINE, J
    LIGHTDALE, CJ
    GASTROINTESTINAL ENDOSCOPY, 1993, 39 (02) : 276 - 276
  • [46] A PROSPECTIVE-STUDY OF DIAGNOSTIC METHODS IN ADENOMA FOLLOW-UP
    WILLIAMS, CB
    MACRAE, FA
    BARTRAM, CI
    ENDOSCOPY, 1982, 14 (03) : 74 - 78
  • [47] RAPIDIRON Trial follow-up study - the RAPIDIRON-KIDS Study: protocol of a prospective observational follow-up study
    Derman, Richard J.
    Bellad, Roopa B.
    Bellad, Mrutyunjaya B.
    Bradford-Rogers, Jesse
    Georgieff, Michael K.
    Aghai, Zubair H.
    Thind, Simal
    Auerbach, Michael
    Boelig, Rupsa
    Leiby, Benjamin E.
    Short, Vanessa
    Yogeshkumar, S.
    Charantimath, Umesh S.
    Somannavar, Manjunath S.
    Mallapur, Ashalata A.
    Pol, Ramesh
    Ramadurg, Umesh
    Sangavi, Radha
    Peerapur, Basavaraj V.
    Banu, Nasima
    Patil, Praveen S.
    Patil, Amaresh P.
    Roy, Subarna
    Vastrad, Phaniraj
    Wallace, Dennis
    Shah, Hemang
    Goudar, Shivaprasad S.
    TRIALS, 2023, 24 (01)
  • [48] RAPIDIRON Trial follow-up study — the RAPIDIRON-KIDS Study: protocol of a prospective observational follow-up study
    Richard J. Derman
    Roopa B. Bellad
    Mrutyunjaya B. Bellad
    Jesse Bradford-Rogers
    Michael K. Georgieff
    Zubair H. Aghai
    Simal Thind
    Michael Auerbach
    Rupsa Boelig
    Benjamin E. Leiby
    Vanessa Short
    S. Yogeshkumar
    Umesh S. Charantimath
    Manjunath S. Somannavar
    Ashalata A. Mallapur
    Ramesh Pol
    Umesh Ramadurg
    Radha Sangavi
    Basavaraj V. Peerapur
    Nasima Banu
    Praveen S. Patil
    Amaresh P. Patil
    Subarna Roy
    Phaniraj Vastrad
    Dennis Wallace
    Hemang Shah
    Shivaprasad S. Goudar
    Trials, 24
  • [49] Loss to follow-up in an international, multicentre observational study
    Mocroft, A.
    Kirk, O.
    Aldins, P.
    Chies, A.
    Blaxhult, A.
    Chentsova, N.
    Vetter, N.
    Dabis, F.
    Gatell, J.
    Lundgren, J. D.
    HIV MEDICINE, 2008, 9 (05) : 261 - 269
  • [50] Nonsteroidal Anti-inflammatory Drug Use After 3 Years of Aspirin Use and Colorectal Adenoma Risk: Observational Follow-up of a Randomized Study
    Grau, Maria V.
    Sandler, Robert S.
    McKeown-Eyssen, Gail
    Bresalier, Robert S.
    Haile, Robert W.
    Barry, Elizabeth L.
    Ahnen, Dennis J.
    Gui, Jiang
    Summers, Robert W.
    Baron, John A.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (04) : 267 - 276